Intranasal dexmedetomidine sedation for EEG in children with autism spectrum disorder.

ABSTRACT:

Introduction

The aim of the study was to assess the efficacy of In-Dex sedation in comparison to oral melatonin and hydroxyzine in individuals with Autism Spectrum Disorder (ASD) undergoing EEG recording and 15 determine which categories of patients exhibit the most favorable response to In-Dex sedation.

Methods

This retrospective observational study involved pediatric patients with ASD who underwent sleep-EEG recording across two periods, before (biennium 2018-19) and after (biennium 2021-22) the routine implementation of In-Dex sedation. Clinical, EEG, and sedation data were stored in a database. A logistic multiple regression model was employed, with the failure of EEG serving as the dependent variable.

Results

In the first period 203 EEGs were performed with a rat

SUBMITTER: De Laurentiis A 

PROVIDER: S-EPMC11499934 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature